Filtered By:
Specialty: Cardiology
Procedure: Heart Valve Surgery
This page shows you your search results in order of date. This is page number 20.
Order by Relevance | Date
Total 1031 results found since Jan 2013.
Impact of mitral versus aortic bioprosthetic valve position on thromboembolism and bleeding risk in patients with atrial fibrillation
CONCLUSIONS: In Japanese patients with AF and bioprosthetic valves, thromboembolic risk does not differ on the basis of valve position. Bleeding risk is higher in patients with MV bioprostheses, although valve position itself might not be an independent predictor for bleeding.PMID:34716054 | DOI:10.1016/j.jjcc.2021.10.002
Source: Journal of Cardiology - October 30, 2021 Category: Cardiology Authors: Yuki Obayashi Makoto Miyake Masashi Amano Takeshi Kitai Misa Takegami Kunihiro Nishimura Toshihiro Tamura Yutaka Furukawa Chisato Izumi Source Type: research
"Simple" Transcatheter Aortic Valve Replacement With Conscious Sedation: Safety and Effectiveness in Real-World Practice
Tex Heart Inst J. 2021 Sep 1;48(4):e207528. doi: 10.14503/THIJ-20-7528.ABSTRACTTranscatheter aortic valve replacement (TAVR) is a well-established alternative to open surgical replacement. Strictly selecting low-risk patients and using conscious sedation during TAVR has enabled hospital stays to be safely shortened. We evaluated the safety and effectiveness of a less rigorous patient-selection process involving multidisciplinary case discussions, percutaneous procedures with the use of conscious sedation, and postprocedural care outside an intensive care unit, with the goal of discharging patients from the hospital early. ...
Source: Texas Heart Institute Journal - October 25, 2021 Category: Cardiology Authors: Alexander Postalian Neil E Strickman Briana T Costello Kathryn G Dougherty Zvonimir Krajcer Source Type: research
Transcatheter aortic valve implantation results are not superimposable to surgery in patients with aortic stenosis at low surgical risk
CONCLUSIONS: TAVI and SVAR in the treatment of AS in the patients at low surgical risk are not superimposable. In particular, if 30-day and 1-year mortality, major bleeding and acute kidney injury were significantly lower for TAVI, the need of new PM implantation and paravalvular leak were significantly lower in SAVR. Consequently, we suggest the need of more trials to evaluate the effectiveness of TAVI as routine therapeutic procedure in the treatment of patients with low surgical risk AS.PMID:34622437 | DOI:10.5603/CJ.a2021.0114
Source: Cardiology Journal - October 8, 2021 Category: Cardiology Authors: Maria Cristina Acconcia Marco Alfonso Perrone Domenico Sergi Marco Di Luozzo Massimo Marchei Pasquale De Vico Antonio Sili Scavalli Giuseppe Pannarale Marcello Chiocchi Carlo Gaudio Francesco Romeo Quintilio Caretta Francesco Barill à Source Type: research
